Carregant...
Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan® array and PCR based next-generation sequencing
BACKGROUND: The importance of accurate and affordable mutation calling in fixed pathology samples is becoming increasingly important as we move into the era of personalised medicine. The Affymetrix OncoScan® Array platform is designed to produce actionable mutation calls in archival material. METHOD...
Guardat en:
Publicat a: | BMC Med Genomics |
---|---|
Autors principals: | , , , , , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
BioMed Central
2017
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5357332/ https://ncbi.nlm.nih.gov/pubmed/28315634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-017-0254-5 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|